Literature DB >> 28471862

T-cell Responses to HSV-1 in Persons Who Have Survived Childhood Herpes Simplex Encephalitis.

Mariliis Ott1, Lichen Jing, Lazaro Lorenzo, Jean-Laurent Casanova, Shen-Ying Zhang, David M Koelle.   

Abstract

BACKGROUND: Herpes simplex encephalitis (HSE) after primary herpes simplex virus (HSV)-1 infection can occur in children due to inborn errors of cell-intrinsic immunity in the central nervous system. Paradoxically, symptomatic mucocutaneous HSV-1 recurrences are rare survivors of childhood HSE. T-cell-acquired immunity is thought to be involved in control of recurrent mucocutaneous HSV infection. We thus tested HSV-1-specific immunity in HSE survivors.
METHODS: We obtained serum and peripheral blood mononuclear cells (PBMCs) from participants a median of 13.5 years after HSE. HSV-1 and HSV-2 IgG was detected by type-specific immunoblot. PBMCs from subjects passing quality control criteria were tested using enzyme-linked immunospot assay for CD4 interferon-γ responses with an HSV-1 lysate and for CD8 responses using pooled synthetic HSV-1 peptide CD8 T-cell epitopes. Healthy adult PBMCs were used to standardize assays and as comparators.
RESULTS: All participants were HSV-1 seropositive. Most (23/24) HSE survivors had human leukocyte antigen class I types matching the human leukocyte antigen restriction of the pooled peptides. We detected HSV-specific CD8 T-cell responses in 14 of 24 (58%) HSE survivors and in 9 of 9 healthy HSV-1 seropositive adults. HSV-specific CD4 T-cell responses were present in all 5 HSE subjects tested and in 8 of 9 healthy adults. Response magnitudes were overlapping between subject groups.
CONCLUSIONS: The defects in cell-intrinsic immunity leading to failure to control primary central nervous system HSV-1 infection do not preclude the acquisition of specific immunity or the control of recurrent mucocutaneous HSV infections. The rarity and lack of severe or recurrent mucocutaneous HSV infection in survivors of childhood HSE corresponds with intact adaptive T-cell immunity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28471862      PMCID: PMC5511073          DOI: 10.1097/INF.0000000000001631

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  14 in total

1.  Response determination criteria for ELISPOT: toward a standard that can be applied across laboratories.

Authors:  Zoe Moodie; Leah Price; Sylvia Janetzki; Cedrik M Britten
Journal:  Methods Mol Biol       Date:  2012

2.  Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.

Authors:  Lichen Jing; Jürgen Haas; Tiana M Chong; Joseph J Bruckner; Greg C Dann; Lichun Dong; Joshua O Marshak; Christopher L McClurkan; Tori N Yamamoto; Susanne M Bailer; Kerry J Laing; Anna Wald; Georges M G M Verjans; David M Koelle
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 3.  Exploiting Mucosal Immunity for Antiviral Vaccines.

Authors:  Akiko Iwasaki
Journal:  Annu Rev Immunol       Date:  2016-05-20       Impact factor: 28.527

4.  Practice parameter for the diagnosis and management of primary immunodeficiency.

Authors:  Francisco A Bonilla; David A Khan; Zuhair K Ballas; Javier Chinen; Michael M Frank; Joyce T Hsu; Michael Keller; Lisa J Kobrynski; Hirsh D Komarow; Bruce Mazer; Robert P Nelson; Jordan S Orange; John M Routes; William T Shearer; Ricardo U Sorensen; James W Verbsky; David I Bernstein; Joann Blessing-Moore; David Lang; Richard A Nicklas; John Oppenheimer; Jay M Portnoy; Christopher R Randolph; Diane Schuller; Sheldon L Spector; Stephen Tilles; Dana Wallace
Journal:  J Allergy Clin Immunol       Date:  2015-09-12       Impact factor: 10.793

5.  Age-dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood.

Authors:  Laurent Abel; Sabine Plancoulaine; Emmanuelle Jouanguy; Shen-Ying Zhang; Nora Mahfoufi; Nathalie Nicolas; Vanessa Sancho-Shimizu; Alexandre Alcaïs; Yiqi Guo; Annabelle Cardon; Soraya Boucherit; Dorothée Obach; Thomas Clozel; Lazaro Lorenzo; Daniel Amsallem; Patrick Berquin; Thierry Blanc; Cécile Bost-Bru; Stéphane Chabrier; Brigitte Chabrol; Emmanuel Cheuret; Olivier Dulac; Philippe Evrard; Bénédicte Héron; Leila Lazaro; Josette Mancini; Jean-Michel Pedespan; François Rivier; Louis Vallée; Pierre Lebon; Flore Rozenberg; Jean-Laurent Casanova; Marc Tardieu
Journal:  J Pediatr       Date:  2010-05-31       Impact factor: 4.406

6.  Oral acyclovir suppression and neurodevelopment after neonatal herpes.

Authors:  David W Kimberlin; Richard J Whitley; Wen Wan; Dwight A Powell; Gregory Storch; Amina Ahmed; April Palmer; Pablo J Sánchez; Richard F Jacobs; John S Bradley; Joan L Robinson; Mark Shelton; Penelope H Dennehy; Charles Leach; Mobeen Rathore; Nazha Abughali; Peter Wright; Lisa M Frenkel; Rebecca C Brady; Russell Van Dyke; Leonard B Weiner; Judith Guzman-Cottrill; Carol A McCarthy; Jill Griffin; Penelope Jester; Misty Parker; Fred D Lakeman; Huichien Kuo; Choo Hyung Lee; Gretchen A Cloud
Journal:  N Engl J Med       Date:  2011-10-06       Impact factor: 91.245

7.  HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.

Authors:  Ruchi Srivastava; Arif A Khan; Doran Spencer; Hawa Vahed; Patricia P Lopes; Nhi Thi Uyen Thai; Christine Wang; Thanh T Pham; Jiawei Huang; Vanessa M Scarfone; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Immunol       Date:  2015-01-23       Impact factor: 5.422

8.  A survey on the prevalence of orofacial herpes in France: the INSTANT Study.

Authors:  Gérard Lorette; Anne Crochard; Viviane Mimaud; Pierre Wolkenstein; Jean-François Stalder; Abdelkader El Hasnaoui
Journal:  J Am Acad Dermatol       Date:  2006-06-13       Impact factor: 11.527

9.  Pediatric herpes simplex virus encephalitis: a retrospective multicenter experience.

Authors:  Lena Schleede; Wolfgang Bueter; Sara Baumgartner-Sigl; Thomas Opladen; Katharina Weigt-Usinger; Susanne Stephan; Martin Smitka; Steffen Leiz; Olaf Kaiser; Verena Kraus; Andreas van Baalen; Heino Skopnik; Hans Hartmann; Kevin Rostasy; Thomas Lücke; Ulrike Schara; Martin Häusler
Journal:  J Child Neurol       Date:  2013-01-16       Impact factor: 1.987

Review 10.  Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency.

Authors:  Mirjam van der Burg; Andy R Gennery
Journal:  Eur J Pediatr       Date:  2011-04-09       Impact factor: 3.183

View more
  2 in total

1.  Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time.

Authors:  Mackenzie M Shipley; Daniel W Renner; Mariliis Ott; David C Bloom; David M Koelle; Christine Johnston; Moriah L Szpara
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

Review 2.  Pathogenesis and virulence of herpes simplex virus.

Authors:  Shuyong Zhu; Abel Viejo-Borbolla
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.